Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harvest of Circulating Tumor Cells (CTCs) From Patients With Metastatic Breast Cancer (MBC) Using the Parsortix™ PC1 System

NCT03427450 is registered in ClinicalTrials.gov with Angle plc as lead sponsor.

NCT NCT03427450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03427450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harvest of Circulating Tumor Cells (CTCs) From Patients With Metastatic Breast Cancer (MBC) Using the Parsortix™ PC1 System
Lead sponsor
Angle plc
Phase
Observational
Overall status
Completed
Start date
March 29, 2018
Completion date
December 31, 2019
Enrollment
421 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic, healthy volunteers